[SRT] November 2024 Monthly Review

– Healthcare was the only subsector that gained in November in SRT

– Meanwhile, industrial and office subsectors fell the most in November in SRT

– A notable development this month was MAS’ upward revision to SREIT’s aggregate leverage limit from 45% to 50% with all SREITs subject to minimum ICR of 1.5x; MAS has also added a requirement where REIT manager needs to take action to improve ICR and disclose information when its ICR falls under 1.8x

Source: JPM, as of 2024/12/02

– Since inception, SRT outperformed 55bp gross of TER per annum.

– +49bp outperformance from the ETF’s tax efficiency and +7bp from portfolio positioning and participation in corporate actions.

Source: CSOP, Bloomberg, performance as of 20241129 unless otherwise specified.

“The investment product(s), as mentioned in this document, is/are registered under section 286 of the Securities and Futures Act (Cap. 289) of Singapore (the “SFA”).This material and the information contained in this material shall not be regarded as an offer or solicitation of business in any jurisdiction to any person to whom it is unlawful to offer or solicit business in such jurisdictions. This document is not to be construed as recommendations to buy/sell any above-mentioned securities, or any securities in the above-mentioned sectors or jurisdictions.

CSOP Asset Management Pte. Ltd. (“CSOP”) which prepared this document believes that information in this document is based upon sources that are believed to be accurate, complete, and reliable. However, CSOP does not warrant the accuracy and completeness of the information, and shall not be liable to the recipient or controlling shareholders of the recipient resulting from its use. CSOP is under no obligation to keep the information up-to-date. The provision of this document shall not be deemed as constituting any offer, acceptance, or promise of any further contract or amendment to any contract. The information herein shall not be disclosed, used or disseminated, in whole or part, and shall not be reproduced, copied or made available to others without the written consent of CSOP.

Advice should be sought from a financial adviser regarding the suitability of the investment and/or investment product before making an investment. Investment involves risk. The value of investments, and the income from them, can go down as well as up and an investor may get back less than the amount invested. Past performance is not necessarily indicative of future performance. Investor should read the prospectus and product highlights sheet, which can be obtained on CSOP website or authorized participating dealers, before deciding whether to invest. This document has not been reviewed by the Monetary Authority of Singapore.”